Lawrence Leeman, M.D., M.P.H. – FDA Inspection, Aug 28, 2026

Record Details

This FDA Inspection record concerns Lawrence Leeman, M.D., M.P.H., with an inspection on August 28, 2026, issued by the Denver District Office, covering human drugs.

Company: Lawrence Leeman, M.D., M.P.H.
Inspection Date: August 28, 2026
Product Type: Human Drugs
Office: Denver District Office
Person: Audrey J. Yarbrough (Issuing Officer)

View Company Profile

ID · 8fccce1c-8e65-43c9-b0f7-6280d9dd3f8c

Inspection Facts

Inspection number: 1333360
FDA center: Human Drugs
Project area: Bioresearch Monitoring
Outcome: Form 483 issued

FDA Citations

21 CFR 312.60FD-1572, protocol compliance
21 CFR 312.62(b)Case history records- inadequate or inadequate

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Lawrence Leeman, M.D., M.P.H.

FDA Inspection

Lawrence Leeman, M.D., M.P.H.August 28, 2026